TYRP1 and HIV infectious disease: We hypothesize that HIV infection triggers the accumulation of Aβ plaques, increases the expression and secretion of dysregulated CATB and interacting partners, together with viral toxins and pro-inflammatory factors, activating the overall proteolytic activity in the environment, ultimately contributing to neurocognitive impairment.